Abstract:The modern healthcare system faces an unrelenting threat from microorganisms, as evidenced by global outbreaks of new viral diseases, emerging antimicrobial resistance, and the rising incidence of healthcare-associated infections (HAIs). An effective response to these threats requires rapid and accurate diagnostic tests that can identify causative pathogens at the point of care (POC). Such tests could eliminate diagnostic uncertainties, facilitating patient triaging, minimizing the empiric use of antimicrobial drugs, and enabling targeted treatments. Current standard methods, however, often fail to meet the needs of rapid diagnosis in POC settings. Culture-based assays entail long processing times and require specialized laboratory infrastructure; nucleic acid (NA) tests are often limited to centralized hospitals due to assay complexity and high costs. Here we discuss two new POC tests developed in our groups to enable the rapid diagnosis of infection. The first is nanoPCR that takes advantages of core-shell magnetoplasmonic nanoparticles (MPNs): (i) Au shell significantly accelerates thermocycling via volumetric, plasmonic light-to-heat conversion and (ii) a magnetic core enables sensitive in situ fluorescent detection via magnetic clearing. By adopting a Ferris wheel module, the system expedites multisamples in parallel with a minimal setup. When applied to COVID-19 diagnosis, nanoPCR detected SARS-CoV-2 RNA down to 3.2 copy/μL within 17 min. In particular, nanoPCR diagnostics accurately identified COVID-19 cases in clinical samples (n = 150), validating its clinical applicability. The second is a polarization anisotropy diagnostic (PAD) system that exploits the principle of fluorescence polarization (FP) as a detection modality. Fluorescent probes were designed to alter their molecular weight upon recognizing target NAs. This event modulates the probes' tumbling rate (Brownian motion), which leads to changes in FP. The approach is robust against environmental noise and benefits from the ratiometric nature of the signal readout. We applied PAD to detect clinically relevant HAI bacteria (Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus). The PAD assay demonstrated detection sensitivity down to the single bacterium level and determined both drug resistance and virulence status. In summary, these new tests have the potential to become powerful tools for rapid diagnosis in the infectious disease space. They do not require highly skilled personnel or labor-intensive analyses, and the assays are quick and cost-effective. These attributes will make nanoPCR and PAD well-aligned with a POC workflow to aid physicians to initiate prompt and informed patient treatment.

Advancing Microfluidic Immunity Testing Systems: New Trends for Microbial Pathogen Detection

Advances in Nucleic Acid Assays for Infectious Disease: The Role of Microfluidic Technology

Multiplex Detection of Infectious Diseases on Microfluidic Platforms

Advancements in microfluidic platforms for rapid biomarker diagnostics of infectious diseases

Microfluidics for Rapid Detection of Live Pathogens

Microfluidics-based strategies for molecular diagnostics of infectious diseases

Microfluidics for COVID-19: From Current Work to Future Perspective

Progress in Point-of-Care Testing of Disease Markers Based on Microfluidic Technology

Recent advances in point-of-care testing of COVID-19

Advancing Point-of-care Microbial Pathogens Detection by Material-Functionalized Microfluidic Systems

The development of droplet-based microfluidic virus detection technology for human infectious diseases.

Emerging Trends and Future Prospects in Microfluidic Systems for Prevention and Diagnosis of Infection Pathogens

Microfluidic Point-of-Care (POC) Devices in Early Diagnosis: A Review of Opportunities and Challenges

Development of Integrated Systems for On-Site Infection Detection

Microfluidics-Based Point-of-Care Testing (POCT) Devices in Dealing with Waves of COVID-19 Pandemic: The Emerging Solution

Emerging Microfluidic Tools for Functional Cellular Immunophenotyping: a New Potential Paradigm for Immune Status Characterization.

Application of microfluidic technologies on COVID-19 diagnosis and drug discovery

Microfluidic System for Microbial Pathogen Detection

Microfluidic chip and isothermal amplification technologies for the detection of pathogenic nucleic acid

Advancing Pathogen Detection for Airborne Diseases

Recent Advances in Molecular and Immunological Diagnostic Platform for Virus Detection: A Review